Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series vetter2020daily

The author measured SARS-CoV-2 detected by real-time reverse transcriptase PCR in both oropharyngeal (OPS) and nasopharyngeal (NPS) swabs from five COVID-19 patients in Geneva, Switzerland, up to days 7 and 19 after symptom onset. Cellular and humoral SARS-CoV-2-specific adaptive responses and serology data are currently not included in this dataset.

Analytes

NPS_SARSCoV2

SARS-CoV-2 RNA gene copy concentrations in nasopharyngeal samples. The concentrations were quantified in gene copies per mL.

Biomarker: SARS-CoV-2
Specimen: nasopharyngeal swab
Units: gc/mL
Gene target: unknown
Participants: 5
Negative samples: 2
Positive samples (not quantifiable): 0
Quantifiable samples: 37
Limit of quantification: unknown
Limit of detection: unknown

OPS_SARSCoV2

SARS-CoV-2 RNA gene copy concentrations in oropharyngeal samples. The concentrations were quantified in gene copies per mL.

Biomarker: SARS-CoV-2
Specimen: oropharyngeal swab
Units: gc/mL
Gene target: unknown
Participants: 5
Negative samples: 1
Positive samples (not quantifiable): 0
Quantifiable samples: 34
Limit of quantification: unknown
Limit of detection: unknown